☆ 4.7 Review

Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis

BIOSENSORS-BASEL (2022)

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Lateral flow-based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use

Saloni Agarwal et al.

Summary: The COVID-19 pandemic underscores the necessity of developing ASSURED POCT technology. LAMP-LFA represents a highly sensitive and specific method for nucleic acid amplification, particularly in detecting SARS-CoV-2 N gene. This approach offers quick, accurate detection of the virus within a short timeframe.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Biosensors for the Determination of SARS-CoV-2 Virus and Diagnosis of COVID-19 Infection

Maryia Drobysh et al.

Summary: Monitoring and tracking infection is crucial for controlling the spread of COVID-19. To achieve this, the development and deployment of accurate diagnostic methods are necessary. Biosensing devices, such as electrochemical biosensors, that utilize various detection methods and biomarkers are commonly used to detect the SARS-CoV-2 virus. Immunosensors based on antigen-antibody interaction are particularly useful in label-free mode for sensitive detection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Article Infectious Diseases

Evaluation of a Lateral Flow Immunoassay COVIDTECH® SARS-CoV-2 IgM/IgG Antibody Rapid Test

Julien Exinger et al.

Summary: In this study, the lateral flow immunoassay (LFIA) COVIDTECH (R) SARS-CoV-2 IgM/IgG antibody rapid test was independently evaluated for its application in diagnosing COVID-19 caused by the new coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The results showed that this LFIA method is suitable for serological diagnosis of SARS-CoV-2 in patients after > 14 days since the onset of symptoms.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection
Review Immunology

Innate immunity: the first line of defense against SARS-CoV-2

Michael S. Diamond et al.

Summary: Kanneganti and Diamond review the crucial role of innate immunity in controlling and immunopathology of COVID-19. They discuss how the innate immune system detects and responds to SARS-CoV-2, which can help identify targeted therapeutic approaches to mitigate severe diseases and improve patient outcomes.

NATURE IMMUNOLOGY (2022)

Add to Collection
Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Add to Collection
Article Multidisciplinary Sciences

Population antibody responses following COVID-19 vaccination in 212,102 individuals

Helen Ward et al.

Summary: Population antibody surveillance is crucial for tracking immune responses to COVID-19 vaccinations. The study found that antibody positivity peaks 4-5 weeks after the first dose of the vaccine and then declines. Age, gender, comorbidities, and infection history affect antibody positivity rates.

NATURE COMMUNICATIONS (2022)

Add to Collection
Article Immunology

A Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader for SARS-CoV-2 Neutralizing Antibody Detection

Rui-Lin Huang et al.

Summary: The study explores the use of lateral flow immunoassays coupled with a spectrum-based reader to detect the presence of neutralizing antibodies in both COVID-19-infected and vaccinated patients. The results indicate that this approach has significant diagnostic value and shows a high correlation with conventional enzyme-linked immunosorbent assay results.

VACCINES (2022)

Add to Collection
Article Chemistry, Analytical

Lateral Flow Immunoassay Coupled with Copper Enhancement for Rapid and Sensitive SARS-CoV-2 Nucleocapsid Protein Detection

Tao Peng et al.

Summary: A lateral flow immunoassay (LFIA) based on colloidal gold nanoparticles has been developed for the rapid detection of the nucleocapsid protein (NP) of SARS-CoV-2. The sensitivity of this LFIA was improved through copper deposition-induced signal amplification. The LFIA coupled with the copper enhancement technique is cost-effective, efficient, and highly sensitive, providing an effective approach for the rapid screening, diagnosis, and monitoring of suspected individuals during the COVID-19 outbreak.

BIOSENSORS-BASEL (2022)

Add to Collection
Article Virology

Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies

Massimo Pieri et al.

Summary: This study evaluated the performance of the RapiRead™ reader and TestNOW™ COVID-19 NAb assay compared to chemiluminescence immunoassay (CLIA) methods. The results showed good correlation between the rapid lateral flow immunoassay (LFIA) test system and CLIA methods. The RapiRead™ reader and TestNOW™ COVID-19 NAb assay are quantitative, rapid, and valid methods for detecting SARS-CoV-2 neutralizing antibodies, making them useful tools for screening studies and vaccine efficacy assessment in non-laboratory settings.

ARCHIVES OF VIROLOGY (2022)

Add to Collection
Article Biophysics

Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies

Jong-Hwan Lee et al.

Summary: The study developed an ACE2-based biosensor that can detect S1 mutations and neutralizing antibodies of SARS-CoV-2. The biosensor can detect various variants and the wild-type SARS-CoV-2, distinguishing them based on color differences. This approach will facilitate the development of various biosensors against SARS-CoV-2.

BIOSENSORS & BIOELECTRONICS (2022)

Add to Collection
Article Medical Laboratory Technology

Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology

Lucy Ochola et al.

CLINICS IN LABORATORY MEDICINE (2022)

Add to Collection
Review Environmental Sciences

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic

Rekha Khandia et al.

Summary: Since December 2019, SARS-CoV-2 has been rapidly evolving and mutating, leading to various variants with different levels of infectivity and lethality. The most recent variant of concern is Omicron (B.1.1.529), which has raised concerns about its ability to evade pre-existing immunity and overcome antibody-based therapies. Several theories have been proposed to explain the high number of mutations in Omicron. To successfully handle the ongoing pandemic, a multifaceted approach including rapid diagnosis, genome analysis, vaccination, and updated medical facilities is needed.

ENVIRONMENTAL RESEARCH (2022)

Add to Collection
Article Pediatrics

Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic

Marcelo Comerlato Scotta et al.

Summary: This study evaluated the accuracy of an antibody point-of-care lateral flow immunoassay in a pediatric population and found that the sensitivity was lower in children, indicating that it cannot fully rule out COVID-19 infection in this population.

JORNAL DE PEDIATRIA (2022)

Add to Collection
Article Infectious Diseases

Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals

Farah M. Shurrab et al.

Summary: The performance of the fluorescence LFIA Finecare (TM) 2019-nCoV S-RBD test was evaluated and found to have high sensitivity and specificity, with consistent results compared to reference assays. This test can be used for quantitative measurement of SARS-CoV-2 antibodies and serves as an alternative method to assess antibody response after infection or vaccination in small or non-laboratory settings.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection
Article Engineering, Environmental

A colorimetric sandwich-type bioassay for SARS-CoV-2 using a hACE2-based affinity peptide pair

Qian Zhu et al.

Summary: The study developed a peptide pair based on human ACE2 that can bind to the S-_RBD of SARS-CoV-2, and a colorimetric bioassay was created for fast, simple, and sensitive detection of SARS-CoV-2 protein.

JOURNAL OF HAZARDOUS MATERIALS (2022)

Add to Collection
Article Biotechnology & Applied Microbiology

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants

Jason Z. Zhang et al.

Summary: We developed a protein biosensor that can rapidly and sensitively detect neutralizing antibodies against SARS-CoV-2 variants in serum. The biosensor can accurately differentiate between different samples based on the affinity and abundance of antibody binding, which is superior to traditional competition-based assays.

NATURE BIOTECHNOLOGY (2022)

Add to Collection
Article Chemistry, Analytical

Controlled, partially exfoliated, self-supported functionalized flexible graphitic carbon foil for ultrasensitive detection of SARS-CoV-2 spike protein

Muhammad Adeel et al.

Summary: This paper presents an ultrasensitive and label-free electrochemical immunosensor for monitoring the SARS-CoV-2 spike protein. A self-supported electrode was fabricated by partially exfoliating a flexible graphitic carbon foil, which served as both an antibody immobilization matrix and electron transport channel. The immunosensor showed high reproducibility and specificity in detecting SARS-CoV-2 SP within a wide concentration range.

SENSORS AND ACTUATORS B-CHEMICAL (2022)

Add to Collection
Article Medicine, General & Internal

Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples

Agnija Kivrane et al.

Summary: The developed LFA assay shows potential for SARS-CoV-2 detection in saliva samples. Although the diagnostic accuracy is low, there is an improvement in specificity and positive prediction value when samples are stratified based on the sampling time, indicating room for further improvement.

UPSALA JOURNAL OF MEDICAL SCIENCES (2022)

Add to Collection
Article Immunology

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

Lotus L. van den Hoogen et al.

Summary: This study found that serological responses to Nucleoprotein can help identify SARS-CoV-2 infections after COVID-19 vaccination. Additionally, the study found that high levels of IgG response shortly after vaccination could be explained by prior exposure history.

VACCINE (2022)

Add to Collection
Article Immunology

Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies

Olaf Nickel et al.

Summary: The study compares the diagnostic performance of three lateral flow assays in detecting antibodies after COVID-19 vaccination. The results suggest that these methods have reasonable application in short-term follow-up.

VACCINES (2022)

Add to Collection
Review Immunology

The humoral response and antibodies against SARS-CoV-2 infection

Hai Qi et al.

Summary: This review summarizes key observations of humoral immune responses in people with COVID-19, discusses key features of infection- and vaccine-induced neutralizing antibodies, and explores vaccine designs for inducing broadly protective antibodies against different variants of the SARS-CoV-2 virus.

NATURE IMMUNOLOGY (2022)

Add to Collection
Review Medicine, General & Internal

Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis

Anastasia Tapari et al.

Summary: This article conducts a systematic review and meta-analysis of antigen-based diagnostic tests for COVID-19, comparing different methods and performance. The findings suggest that the performance of tests varies based on sample sources and rapid methods, emphasizing the influence of viral load on test sensitivity.

DIAGNOSTICS (2022)

Add to Collection
Article Biochemistry & Molecular Biology

High Diagnostic Accuracy of a Novel Lateral Flow Assay for the Point-of-Care Detection of SARS-CoV-2

Irene Giberti et al.

Summary: The study assessed the diagnostic performance of the ND COVID-19 LFT under real-world conditions, showing a sensitivity of 85% and specificity of 100%. There was a clear association between sample viral load and false-negative rate, with optimal performance observed in samples with higher viral loads. The findings suggest that the ND LFT is sufficiently accurate and useful for mass population screening programs.

BIOMEDICINES (2022)

Add to Collection
Review Chemistry, Analytical

Progress in Electrochemical Biosensing of SARS-CoV-2 Virus for COVID-19 Management

Md Mahbubur Rahman

Summary: This article comprehensively reviews the latest advances in electrochemical biosensors for COVID-19 diagnosis. These electrochemical sensors can rapidly and cost-effectively detect the SARS-CoV-2 virus from patient's biological fluids by detecting its components, including structural proteins, nucleic acid, and antibodies.

CHEMOSENSORS (2022)

Add to Collection
Review Chemistry, Analytical

A review on the contamination of SARS-CoV-2 in water bodies: Transmission route, virus recovery and recent biosensor detection techniques

Siti Adibah Zamhuri et al.

Summary: The presence of SARS-CoV-2 virus in water bodies due to poor wastewater management poses a risk of transmission to humans. Wastewater-based epidemiology has been used to detect the virus in sewage networks. Challenges in detecting the virus in wastewater include dilution of high virus loading, requiring virus preconcentration from water samples. This review also discusses the limitations of conventional virus detection techniques and the potential of biosensors as an alternative method.

SENSING AND BIO-SENSING RESEARCH (2022)

Add to Collection
Article Infectious Diseases

Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection

Bo Diao et al.

Summary: The FIC assay for NP antigen testing shows high specificity and relatively high sensitivity in early-phase SARS-CoV-2 diagnosis, according to a study conducted in Wuhan and Chongqing between February 10 and 15, 2020.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection
Article Biochemistry & Molecular Biology

The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients

Veronique A. J. Smits et al.

Summary: The study found that COVID-19 patients have a specific immune response against the full length and fragments of the N protein of SARS-CoV-2, with less response towards the S protein fragments and low response towards other S protein fragments and the M protein. This could aid in the development of methods for measuring COVID-19 antibody response and vaccine development.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection
Review Medicine, Research & Experimental

Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative

Isaac Kyei-Barffour et al.

Summary: The rapid development and approval of COVID-19 vaccines offered a swift solution to prevent the collapse of global healthcare system, but more research is needed to determine if these vaccines can induce sterilizing immunity. Variants of SARS-CoV-2 may impact the effectiveness of current vaccines, and data on vaccines that can confer sterilizing immunity is still lacking.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection
Review Microbiology

SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights

Swapnil B. Kadam et al.

Summary: The outbreak of COVID-19 marked the third spillover of an animal coronavirus to humans in the last 20 years, likely originating from bats and possibly transmitted to humans via unknown intermediate host (potentially a pangolin). The causative pathogen, SARS-CoV-2, shares genetic similarities with bat and pangolin coronaviruses in terms of protein structure and genome, suggesting a zoonotic origin.

JOURNAL OF BASIC MICROBIOLOGY (2021)

Add to Collection
Review Medicine, Research & Experimental

Biosensors as a future diagnostic approach for COVID-19

Suhad Abbas Abid et al.

Summary: Biosensors play a crucial role in clinical diagnostics, food processing, and environmental monitoring for detecting viruses. The most common biosensors used for viral detection are optical (e.g., SERS, SPR) and electrochemical biosensors.

LIFE SCIENCES (2021)

Add to Collection
Article Chemistry, Analytical

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and-2 Antibodies Using Upconverting Nanoparticle Reporters

Iida Martiskainen et al.

Summary: Rapid diagnostic tests are commonly used in low- and middle-income countries for detecting HIV antibodies in remote locations with limited access to central laboratories. Luminescent upconverting nanoparticle reporters have been shown to help overcome the risk of misinterpretation in these tests. The developed UCNP-LFA demonstrates the applicability of UCNPs for the detection of anti-HIV antibodies, with potential for automated result interpretation, archiving, and data transfer from decentralized locations.

SENSORS (2021)

Add to Collection
Article Microbiology

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

Guido Papa et al.

Summary: Research suggests that furin plays a promoting role in SARS-CoV-2 infectivity and cell-cell spread, but it is not essential, indicating that furin inhibitors may reduce but not completely prevent viral spread.

PLOS PATHOGENS (2021)

Add to Collection
Article Medicine, General & Internal

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Michael A. Johansson et al.

Summary: The study suggests that more than half of COVID-19 transmission may come from asymptomatic individuals, highlighting the importance of measures beyond identifying and isolating symptomatic cases in controlling the spread of the virus.

JAMA NETWORK OPEN (2021)

Add to Collection
Article Biophysics

Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins

Hye-Yeon Kim et al.

Summary: This study presents the development of a specific LFIA-based biosensor for COVID-19 using phage display technology to generate antibodies targeting SARS-CoV-2 NP antigen, allowing rapid and specific detection of the virus. The newly developed rapid diagnostic test shows potential for use in the diagnosis of COVID-19.

BIOSENSORS & BIOELECTRONICS (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. Garcia-Beltran et al.

Summary: New variants of SARS-CoV-2 show high resistance to vaccine neutralization, with some able to escape vaccine responses with just a few mutations, highlighting the importance of developing broadly protective measures against variants.

CELL (2021)

Add to Collection
Review Chemistry, Physical

Diagnostics for SARS-CoV-2 infections

Bhavesh D. Kevadiya et al.

Summary: The outbreak of SARS-CoV-2 causing COVID-19 has led to diverse and severe symptoms, making accurate diagnosis a key challenge. Rapid diagnosis and treatment measures are crucial in controlling the spread of the virus. The development of diagnostic tools, including nanomaterial-based ones, is essential in the fight against the pandemic.

NATURE MATERIALS (2021)

Add to Collection
Article Chemistry, Analytical

SERS-based lateral flow immunoassay for sensitive and simultaneous detection of anti-SARS-CoV-2 IgM and IgG antibodies by using gap-enhanced Raman nanotags

Shiliang Chen et al.

Summary: The newly developed SERS-based LFIA strip using GERTs achieved highly sensitive detection of anti-SARS-CoV-2 IgM and IgG, with detection limits 100 times lower compared to conventional LFIA strips, improving the accuracy and reliability of early diagnosis.

SENSORS AND ACTUATORS B-CHEMICAL (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63

Darina Bacenkova et al.

Summary: COVID-19, caused by SARS-CoV-2, has ACE-2 identified as the receptor for viral entry and plays a key role in the cardiovascular system.

APPLIED SCIENCES-BASEL (2021)

Add to Collection
Article Immunology

The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients

Huanle Luo et al.

Summary: Increasing evidence suggests immune responses are associated with COVID-19 outcomes. IgG subclasses and cytokines had significant correlations with disease severity. Older patients and those with comorbidities showed higher antibody levels and affected IgG1 and IgG3 responses.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Multidisciplinary Sciences

Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection

Silvia Novello et al.

Summary: This study investigated the antibody response to SARS-CoV-2 in different groups, finding varying seroconversion rates and levels of antibodies. Factors such as male gender, close contact with COVID-19 cases, and presence of symptoms were strongly associated with serological positivity. The study suggests that qualitative and quantitative antibody testing is a reliable tool for disease surveillance.

SCIENTIFIC REPORTS (2021)

Add to Collection
Editorial Material Medicine, General & Internal

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

Trisha Greenhalgh et al.

LANCET (2021)

Add to Collection
Review Chemistry, Analytical

The Challenges of Developing Biosensors for Clinical Assessment: A Review

Briliant Adhi Prabowo et al.

Summary: Emerging research in biosensors, particularly in response to the COVID-19 pandemic, has attracted global attention. Challenges remain for researchers in terms of biosensor platform preferences, biomarker selection, and detection strategies, while physicians seek fast and efficient diagnostic tools for early diagnosis and patient stratification.

CHEMOSENSORS (2021)

Add to Collection
Article Chemistry, Analytical

Quantitative Spectrochip-Coupled Lateral Flow Immunoassay Demonstrates Clinical Potential for Overcoming Coronavirus Disease 2019 Pandemic Screening Challenges

Kai-Feng Hung et al.

Summary: As COVID-19 continues to spread, the use of lateral flow immunoassay devices and spectrochip technology enables quantitative analysis and high sensitivity in detecting anti-SARS-CoV-2 antibodies. The innovative device allows for early detection of infection and potential clinical benefits for patients.

MICROMACHINES (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Comparative Study of Gold and Carbon Nanoparticles in Nucleic Acid Lateral Flow Assay

Juan Carlos Porras et al.

Summary: Lateral flow assay (LFA) is a paper-based test designed for detecting specific analytes in low-resource settings. While colloidal gold is commonly used for detection, carbon nanoparticles (CNPs) have shown to be more sensitive, cost-effective, and stable, making them promising alternatives for improving the detection technology.

NANOMATERIALS (2021)

Add to Collection
Review Respiratory System

False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives

Dimitra S. Mouliou et al.

Summary: The accuracy of SARS-CoV-2 diagnostic assays is crucial in minimizing falsely tested cases, with factors such as clinical characteristics and vaccination impacting existing diagnostic assays. Future research in evaluating lung tissue innate immune responses holds promise in optimizing testing accuracy for SARS-CoV-2 and future infections.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Add to Collection
Review Respiratory System

The immune response to SARS-CoV-2 and COVID-19 immunopathology -- Current perspectives

J. L. Boechat et al.

Summary: SARS-CoV-2 is a new beta coronavirus responsible for COVID-19, declared a pandemic by the World Health Organization. Control of the pandemic has been hindered by limited knowledge of the virus-host interactions. The rapid clinical course of COVID-19 is linked to innate immune response in asymptomatic or mild cases.

PULMONOLOGY (2021)

Add to Collection
Review Chemistry, Analytical

Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease

Riccarda Antiochia

Summary: This review summarizes the current state of paper-based biosensors (PBBs) used in the detection of COVID-19, specifically focusing on three categories for SARS-CoV-2 diagnostics. It highlights the characteristics, analytical performance, advantages and drawbacks of each type of biosensor compared to traditional methods, with the hope of assisting scientists in developing novel PBB platforms with enhanced performance to help contain the COVID-19 outbreak.

BIOSENSORS-BASEL (2021)

Add to Collection
Article Nanoscience & Nanotechnology

Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay

Chongwen Wang et al.

Summary: A dual-mode lateral flow immunoassay biosensor was developed for high-sensitivity simultaneous detection of SARS-CoV-2 spike and nucleocapsid protein antigens, offering enhanced accuracy and efficiency in viral infection screening. The system demonstrated superior performance in detecting SARS-CoV-2 antigens in saliva and nasal swab samples, with detection limits of 1 and 0.5 pg/mL for the spike and nucleocapsid protein antigens, respectively.

ACS APPLIED MATERIALS & INTERFACES (2021)

Add to Collection
Review Infectious Diseases

A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2

Dylan A. Mistry et al.

Summary: This systematic review found that the performance of lateral flow devices is heterogeneous and dependent on the manufacturer. Some devices have high specificity but a great range of sensitivities were shown (38.32-99.19%). Test performance does not appear to be dependent on the operator.

BMC INFECTIOUS DISEASES (2021)

Add to Collection
Letter Immunology

Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection

Hao Wang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation

Lucy G. Thorne et al.

Summary: SARS-CoV-2 infection leads to broad-spectrum immunopathological diseases, exacerbated by inflammatory co-morbidities. Research shows that the virus replicates rapidly in lung epithelial cells and triggers a robust innate immune response, affecting macrophage activation through inflammatory mediators produced during infection. Further exacerbation of the local inflammatory environment occurs when macrophages or epithelial cells are primed with exogenous inflammatory stimuli.

EMBO JOURNAL (2021)

Add to Collection
Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection
Article Multidisciplinary Sciences

Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L

Kartikay Prasad et al.

Summary: Genomic analysis and drug screening identified estradiol and retinoic acid as potential agents for treating SARS-CoV-2. These drugs interact with human proteins, suggesting the therapeutic benefits of targeting the virus entry pathways.

PLOS ONE (2021)

Add to Collection
Article Multidisciplinary Sciences

The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic

Pang-Yen Chen et al.

Summary: A new optical platform is developed in this study for quantitative detection of antibodies in COVID-19 patients, showing significant advantages over other serum antibody reagents on the market. Early identification of elevated IgM levels in relation to COVID-19 infection is found, and the platform demonstrates sensitivity and accuracy in detecting RT-PCR negative patients.

PLOS ONE (2021)

Add to Collection
Article Chemistry, Analytical

Development of a rapid and sensitive quantum dot nanobead-based double-antigen sandwich lateral flow immunoassay and its clinical performance for the detection of SARS-CoV-2 total antibodies

Yaofeng Zhou et al.

Summary: The study successfully developed highly luminescent quantum dot nanobeads for rapid and accurate measurement of total antibody concentrations in the population, which is crucial for combating the COVID-19 pandemic.

SENSORS AND ACTUATORS B-CHEMICAL (2021)

Add to Collection
Article Microbiology

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection

Martina Severa et al.

Summary: The study highlights the crucial role of pDC/type I IFN axis in defending against SARS-CoV-2 infection in COVID-19 patients, suggesting that a deeper understanding may aid in the development of new drug strategies and host-directed therapies. Moreover, the findings indicate that critically ill patients exhibit impaired type I IFN response and high levels of inflammatory cytokines and chemokines, leading to multi-organ failure.

PLOS PATHOGENS (2021)

Add to Collection
Editorial Material Critical Care Medicine

SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission

Elizabeth Fearon et al.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs

Enqing Tan et al.

Summary: Identifying antibodies with strong neutralizing activity against current variants of SARS-CoV-2 is crucial for developing therapeutic solutions. Our study characterized seven anti-SARS-CoV-2 RBD antibodies and grouped them based on binding and neutralization activity. Lateral flow immunoassay proved to be a rapid and effective tool for antibody characterization, including epitope classification and neutralization kinetics.

DIAGNOSTICS (2021)

Add to Collection
Review Medicine, General & Internal

SARS-CoV-2 Variants of Concern

Jun Yong Choi et al.

Summary: Since the beginning of the COVID-19 pandemic, the SARS-CoV-2 virus has evolved into various variants, with some designated as VOCs that have higher transmissibility and disease severity, potentially impacting vaccine effectiveness.

YONSEI MEDICAL JOURNAL (2021)

Add to Collection
Article Infectious Diseases

Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2

Vandana Vijayeta Kiro et al.

Summary: The study evaluated the performance of the STANDARD F COVID-19 antigen FIA kit, showing that it had high specificity and positive predictive value, but low sensitivity and negative predictive value.

JOURNAL OF GLOBAL INFECTIOUS DISEASES (2021)

Add to Collection
Article Medicine, General & Internal

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

Tim Peto

Summary: The study found that four LFDs have desirable performance characteristics in viral antigen detection, with Innova LFD showing good sensitivity and specificity. The potential issues of kit failure rates and training impact were noted. LFDs can be used for mass population testing to identify infectious individuals.

ECLINICALMEDICINE (2021)

Add to Collection
Review Medicine, General & Internal

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

Jacqueline Dinnes et al.

Summary: Accurate and rapid diagnostic tests for SARS-CoV-2 infection are crucial for managing the COVID-19 pandemic. Point-of-care antigen and molecular tests can increase access to testing and expedite clinical and public health management decisions. Studies show that antigen tests have varying sensitivity, with higher accuracy in the first week of infection, and the efficacy of molecular tests depends on the specific brand used.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Protein-based lateral flow assays for COVID-19 detection

Farbod Mahmoudinobar et al.

Summary: In order to combat the spread of COVID-19, rapid diagnostic innovations based on protein-protein interactions have been developed, particularly antigen tests using the LFA test platform. Despite the convenience and lower cost of these tests, they have faced criticism for lower sensitivity, prompting recent efforts to create rapid LFA tests with higher limit of detection.

PROTEIN ENGINEERING DESIGN & SELECTION (2021)

Add to Collection
Review Chemistry, Analytical

Rapid developments in lateral flow immunoassay for nucleic acid detection

Chujun Zheng et al.

Summary: This review discusses two main research directions of lateral flow nucleic acid tests, one involving the incorporation of isothermal amplification methods for increased sensitivity, and the other focusing on the development of novel labeling materials for improved quantifiability. Future research will focus on integrating the entire testing process into microfluidic systems and combining with molecular diagnostic tools to facilitate rapid and accurate testing.

ANALYST (2021)

Add to Collection
Article Chemistry, Analytical

Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay

Zhenhua Chen et al.

ANALYTICAL CHEMISTRY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

The Architecture of SARS-CoV-2 Transcriptome

Dongwan Kim et al.

CELL (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

CELL (2020)

Add to Collection
Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection
Article Immunology

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Li Guo et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection
Article Infectious Diseases

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients

J. Van Elslande et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Add to Collection
Letter Infectious Diseases

Authors' response: SARS-CoV-2 detection by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Add to Collection
Editorial Material Public, Environmental & Occupational Health

Commentary: SARS, MERS and COVID-19-new threats; old lessons

Gwendolyn L. Gilbert

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)

Add to Collection
Editorial Material Medicine, General & Internal

Interpreting Diagnostic Tests for SARS-CoV-2

Nandini Sethuraman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection
Article Multidisciplinary Sciences

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Kai Duan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection
Editorial Material Microbiology

Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19

Robin Patel et al.

MBIO (2020)

Add to Collection
News Item Medicine, General & Internal

Covid-19: FDA approves use of convalescent plasma to treat critically ill patients

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection
Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection
Review Infectious Diseases

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

Nikhil Kirtipal et al.

INFECTION GENETICS AND EVOLUTION (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Development of a Sensitive Immunochromatographic Method Using Lanthanide Fluorescent Microsphere for Rapid Serodiagnosis of COVID-19

Meng Feng et al.

ACS SENSORS (2020)

Add to Collection
Article Virology

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Thomas Nicol et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection
Article Pathology

Humoral Immune Response to SARS-CoV-2 Comparative Clinical Performance of Seven Commercial Serology Tests

Pauline H. Herroelen et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Add to Collection
Review Biophysics

Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape

Neeraja Ravi et al.

BIOSENSORS & BIOELECTRONICS (2020)

Add to Collection
Article Multidisciplinary Sciences

Improvement in Detection Limit for Lateral Flow Assay of Biomacromolecules by Test-Zone Pre-enrichment

Yi Zhang et al.

SCIENTIFIC REPORTS (2020)

Add to Collection
Editorial Material Medicine, Research & Experimental

SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy

Arturo Casadevall et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection
Article Biochemical Research Methods

Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections

Pei Wang

JOURNAL OF VIROLOGICAL METHODS (2020)

Add to Collection
Article Ophthalmology

ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection

Lingli Zhou et al.

OCULAR SURFACE (2020)

Add to Collection
Article Microbiology

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

Etienne Brochot et al.

FRONTIERS IN MICROBIOLOGY (2020)

Add to Collection
Review Critical Care Medicine

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Daniel E. Leisman et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection
Article Microbiology

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

Carolin Loos et al.

MSPHERE (2020)

Add to Collection
Article Biophysics

Facile biosensors for rapid detection of COVID-19

Lizhou Xu et al.

BIOSENSORS & BIOELECTRONICS (2020)

Add to Collection
Article Biochemical Research Methods

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection

Pranesh Padmanabhan et al.

PLOS COMPUTATIONAL BIOLOGY (2020)

Add to Collection
Article Microbiology

Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays

Moise Michel et al.

FRONTIERS IN MICROBIOLOGY (2020)

Add to Collection
Review Immunology

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Yannick Galipeau et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Review Cell Biology

Taming the Autophagy as a Strategy for Treating COVID-19

Blanca Estela Garcia-Perez et al.

CELLS (2020)

Add to Collection
Article Engineering, Biomedical

Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA

Daming Wang et al.

NATURE BIOMEDICAL ENGINEERING (2020)

Add to Collection
Article Multidisciplinary Sciences

SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain

Leon Fodoulian et al.

ISCIENCE (2020)

Add to Collection
Article Virology

Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand

Chutikarn Chaimayo et al.

VIROLOGY JOURNAL (2020)

Add to Collection
Review Microbiology

Six decades of lateral flow immunoassay: from determining metabolic markers to diagnosing COVID-19

Boris G. Andryukov

AIMS MICROBIOLOGY (2020)

Add to Collection
Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

Nisreen M. A. Okba et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection
Article Chemistry, Analytical

Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus

Tian Wen et al.

ANALYST (2020)

Add to Collection
Article Genetics & Heredity

Genomic characterization of a novel SARS-CoV-2

Rozhgar A. Khailany et al.

GENE REPORTS (2020)

Add to Collection
Article Immunology

US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Xiaoyan Lu et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection
Review Medicine, General & Internal

Coronaviruses and SARS-COV-2

Mustafa Hasoksuz et al.

TURKISH JOURNAL OF MEDICAL SCIENCES (2020)

Add to Collection
Article Immunology

Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients

Zhang Yongchen et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection
Article Nanoscience & Nanotechnology

Magnetic SERS Strip for Sensitive and Simultaneous Detection of Respiratory Viruses

Chongwen Wang et al.

ACS APPLIED MATERIALS & INTERFACES (2019)

Add to Collection
Review Chemistry, Analytical

Multiplex Lateral Flow Immunoassay: An Overview of Strategies towards High-throughput Point-of-Need Testing

Laura Anfossi et al.

BIOSENSORS-BASEL (2018)

Add to Collection
Review Biochemistry & Molecular Biology

Lateral flow assays

Katarzyna M. Koczula et al.

BIOSENSOR TECHNOLOGIES FOR DETECTION OF BIOMOLECULES (2016)

Add to Collection
Review Medicine, Research & Experimental

Advances in biosensors: Principle, architecture and applications

Veeradasan Perumal et al.

JOURNAL OF APPLIED BIOMEDICINE (2014)

Add to Collection
Article Immunology

Better Tests, Better Care: Improved Diagnostics for Infectious Diseases

Angela M. Caliendo et al.

CLINICAL INFECTIOUS DISEASES (2013)

Add to Collection
Review Infectious Diseases

Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing

L. Bissonnette et al.

CLINICAL MICROBIOLOGY AND INFECTION (2010)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.